12:00 AM
Feb 07, 2011
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

BioCancell preclinical data

In a mouse model of glioblastoma, BC-821 significantly reduced tumor growth by 60% compared to untreated controls....

Read the full 61 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >